Significantly more patients were on angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin II-receptor blockers (ARBs), calcium channel blockers (CCBs), and diuretics, while only a slightly larger number of patients were on beta-blockers during the 1st week after stroke than before stroke. The gene discussed is ACE; the disease is stroke disorder.